Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 2/20 | 0.37 |
| ▸ | NOS1 | P29475 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9152654 | 0.92 | SIGMAR1 (0.34) | ARG1 | |
| SCHEMBL2921370 | 0.88 | — | — | |
| SCHEMBL294191 | 0.82 | ARG1 (0.33) | ARG1 | |
| SCHEMBL5146389 | 0.82 | ARG1 (0.35) | ARG1 | |
| SCHEMBL295566 | 0.80 | ARG1 (0.32) | ARG1 | |
| SCHEMBL5662351 | 0.80 | ARG1 (0.34) | ARG1 | |
| SCHEMBL7511004 | 0.80 | NOS1 (0.38) | ARG1NOS1NOS2 | |
| SCHEMBL27601530 | 0.80 | ARG1 (0.32) | ARG1 | |
| SCHEMBL4068138 | 0.80 | ARG1 (0.32) | ARG1 | |
| SCHEMBL3429882 | 0.80 | ARG1 (0.34) | ARG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113929642-B | Dehydroabietylamine silver ion fluorescent probe and preparation method thereof | 南京林业大学 | 2023-04-11 | — | — | CN | claimed |
| CN-111133085-A | Nitrogen functionalized olefin polymers for driveline lubricants | 路博润公司 | 2020-05-08 | — | — | CN | claimed |
| US-6846827-B1 | Pyrimidine derivatives | ASTRAZENECA AB (SE) | 2005-01-25 | — | — | US | claimed |
| EP-1226126-B1 | PYRIMIDINE DERIVATIVES | ASTRAZENECA AB (SE) | 2005-01-05 | — | — | EP | claimed |
| EP-1226126-A1 | PYRIMIDINE DERIVATIVES | AstraZeneca AB (SE) | 2002-07-31 | — | — | EP | claimed |
| WO-2001027089-A1 | PYRIMIDINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-04-19 | — | — | WO | claimed |
| CN-122029238-A | Curable composition and cured product | 株式会社钟化 | 2026-05-12 | — | — | CN | disclosed |
| WO-2025122389-A1 | CHEMICAL ADDITIVES FOR CHEMICAL MECHANICAL PLANARIZATION (CMP) POLISHING COMPOSITIONS | VERSUM MATERIALS US, LLC (US) | 2025-06-12 | — | — | WO | disclosed |
| WO-2024231543-A1 | CANNABINOID DERIVATIVES FOR TREATING AUTISM SPECTRUM DISORDER | GB LAB (FR) | 2024-11-14 | — | — | WO | disclosed |
| EP-4429646-A1 | NOVEL CANNABINOID DERIVATIVES | Cannasoul Analytics Ltd. (IL) | 2024-09-18 | — | — | EP | disclosed |
| WO-2023084516-A1 | NOVEL CANNABINOID DERIVATIVES | CANNASOUL ANALYTICS LTD. (IL) | 2023-05-19 | — | — | WO | disclosed |
| CN-115975187-A | Highly branched poly (beta-amino ester), preparation method thereof and application thereof in functional DNA delivery | 复旦大学附属儿科医院 | 2023-04-18 | — | — | CN | disclosed |
| CN-108148058-B | 4- (2-mercaptothiadiazole) substituted pyrimidine derivative, and preparation method and application thereof | 中国人民解放军第四军医大学 | 2021-03-16 | — | — | CN | disclosed |
| US-5958935-A | Substituted 2-anilinopyrimidines useful as protein kinase inhibitors | CELLTECH THERAPEUTICS LIMITED (GB) | 1999-09-28 | — | — | US | disclosed |
| EP-0862560-A1 | SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS | CELLTECH THERAPEUTICS LIMITED (GB) | 1998-09-09 | — | — | EP | disclosed |
| EP-0575954-B1 | Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process | MEDIOLANUM FARMACEUTICI SRL (IT) | 1998-09-02 | — | — | EP | disclosed |
| WO-1997019065-A1 | SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS | CELLTECH THERAPEUTICS LIMITED (GB) | 1997-05-29 | — | — | WO | disclosed |
| US-5424451-A | Used as cholinesterase activity inhibitors | MEDIOLANUM FARMACEUTICI S.P.A. (IT) | 1995-06-13 | — | — | US | disclosed |
| US-5302593-A | Aminoalkylcarbamic esters of eseroline suitable for use as chlorinesterase activity inhibitors | MEDIOLANUM FARMACEUTICI S.P.A. (IT) | 1994-04-12 | — | — | US | disclosed |
| EP-0575954-A1 | Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process | MEDIOLANUM FARMACEUTICI S.P.A. (IT) | 1993-12-29 | — | — | EP | disclosed |